With the range of interventional modalities that are available for metastatic liver tumors, when should you advocate for thermal ablation at the tumor board? In this episode of BackTable, host Dr. Sabeen Dhand welcomes back Dr. Jason Hoffman, an interventional radiologist from New York University, to discuss tools, techniques, and multidisciplinary collaboration around microwave ablation for liver metastases.

---

This podcast is supported by:

Varian

---

SYNPOSIS

The physicians discuss the decision-making process behind using microwave ablation for metastatic liver disease, and strategies for advocating for the technology in tumor boards. Dr. Hoffman especially emphasizes the value of educating patients about their options and using thoughtful clinical judgement as an IR. The discussion delves into the benefits and advancements in microwave ablation, including his experience with the Varian system in light of NeuWave’s discontinuation. Dr. Hoffman shares the utility of software guidance, system fusion with CT machines, temperature monitoring, and the ability to achieve a more spherical ablation zone.

---

TIMESTAMPS

00:00 - Introduction
04:39 - Practice Growth
11:10 - Microwave Ablation Technology
12:43 - Multidisciplinary Approach to Liver Metastases
26:48 - Microwave Technology and Probe Placement
28:42 - Guidance Software and Technological Integration
30:40 - Planning and Intraoperative Decisions
40:28 - Future of Microwave Ablation
48:35 - Conclusion and Final Thoughts